SequelSEC

BIO KEY INTERNATIONAL INC BKYI

Services-Prepackaged Software · CIK 0001019034 · Fiscal year ends 1231

Revenue
$5.94M
Fiscal year ended 2025-12-31
Operating income
-$6.83M
Fiscal year ended 2025-12-31
Free cash flow
-$4.68M
Fiscal year ended 2025-12-31

Valuation, from the filing

Public float$4.93MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$4.55Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue0.8×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity1.0×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Services-Prepackaged Software filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
FCF margin-78.8%9th
CapEx / revenue0.2%12th
Revenue YoY growth-14.3%13th
Operating margin-115.0%16th
Net margin-120.6%17th
R&D / revenue44.0%82th
Gross margin76.9%67th
Current ratio1.47x50th

BIO KEY INTERNATIONAL INC (BKYI) reported revenue of $5.94M and net income of -$7.16M for the fiscal year ended 2025-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from BIO KEY INTERNATIONAL INC’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Prepackaged Software.

Income

BIO KEY INTERNATIONAL INC income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$5.94M$6.93M$7.75M$7.02M$5.11M$2.84M$2.27M$4.04M$6.30M$2.98M
Cost of revenue$1.37M$1.29M$6.32M$2.44M$1.67M$794.83K$2.46M$4.16M$3.24M$729.68K
Gross profit$4.56M$5.64M$1.43M$4.58M$3.44M$2.04M-$193.72K-$119.65K$3.06M$2.25M
Operating income-$6.83M-$4.01M-$8.83M-$9.92M-$4.94M-$5.20M-$1.07M$80-$4.28M-$4.20M
Net income-$7.16M-$4.30M-$8.52M-$11.91M-$5.07M-$9.67M-$14.59M-$6.87M-$4.28M-$4.19M
Research & development$2.61M$2.51M$2.39M$3.25M$2.36M$1.40M$1.33M$1.42M$1.66M$2.01M
Weighted-average diluted sharesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Pretax income-$7.14M-$4.32M-$8.66M-$11.93M$0UnavailableUnavailableUnavailableUnavailableUnavailable
Income tax expense$16.50K-$23.00K-$134.01K-$20.43K$0$0$0$0$0-$12.12K
Diluted EPSUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Selling, general & administrative$6.28M$7.14M$7.86M$9.36M$6.03M$5.85M$5.04M$5.33M$5.68M$4.44M
General & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

BIO KEY INTERNATIONAL INC balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Cash & equivalents$2.69M$437.60K$511.40K$2.64M$7.75M$16.99M$79.01K$323.94K$288.72K$1.06M
Total assets$8.30M$8.62M$4.52M$11.34M$17.77M$22.52M$2.50M$11.69M$16.08M$17.29M
Current assets$4.54M$1.89M$2.62M$8.98M$14.01M$18.94M$1.37M$4.23M$7.01M$4.91M
Total liabilities$3.20M$4.84M$3.45M$6.04M$2.15M$2.19M$4.78M$1.23M$2.33M$1.84M
Current liabilities$3.10M$4.55M$3.21M$5.46M$2.00M$1.88M$4.39M$1.23M$2.33M$1.84M
Total equity incl. NCI$5.11M$3.77M$1.06M$5.30M$15.62M$20.34M-$2.29M$10.47M$13.75M$15.45M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Inventory$370.88K$378.31K$445.74K$4.43M$4.94M$330.95K$429.12K$998.83K$946.85K$465.43K
Accounts receivable$1.22M$718.23K$1.20M$1.52M$970.63K$548.05K$126.00K$1.57M$2.88M$1.56M
GoodwillUnavailableUnavailableUnavailable$0$1.26M$1.26MUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailable$44.76K$188.79K$326.77K$0UnavailableUnavailableUnavailableUnavailableUnavailable
Accounts payable$507.36K$818.19K$1.32M$1.11M$427.77K$244.16K$844.56K$481.27K$499.23K$466.84K

Cash flow

BIO KEY INTERNATIONAL INC cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Operating cash flow-$4.67M-$2.91M-$3.79M-$6.23M-$8.98M-$4.95M-$1.85M-$1.61M-$2.47M-$4.45M
Capital expenditures$12.01K$13.05K$1.00K$82.04K$42.02K$35.57K$28.75K$52.06K$166.06K$52.98K
Investing cash flow-$12.01K-$13.05K-$1.00K-$696.62K-$42.02K-$2.23M-$543.31K-$82.46K-$226.76K-$52.98K
Financing cash flow$6.91M$2.83M$1.43M$1.90M-$218.60K$24.09M$2.15M$1.73M$1.92M$1.24M
Net change in cash$2.26M-$73.80K-$2.12M-$5.12M-$9.24M$16.91M-$244.93K$35.22K-$772.59K-$3.26M
Stock-based compensationUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable$942.69K$940.73K$260.84K
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortization$84.46K$93.03K$75.14K$43.79KUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Derived

BIO KEY INTERNATIONAL INC derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Free cash flow-$4.68M-$2.93M-$3.79M-$6.31M-$9.02M-$4.99M-$1.88M-$1.67M-$2.63M-$4.50M
Gross margin76.9%81.4%18.5%65.2%67.3%72.0%-8.5%-3.0%48.6%75.5%
Operating margin-115.0%-57.9%-113.8%-141.4%-96.6%-183.4%-47.1%0.0%-67.8%-141.2%
FCF margin-78.8%-42.2%-48.9%-89.9%-176.4%-175.8%-82.9%-41.2%-41.8%-151.2%
SBC / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable14.9%8.8%
Current ratio1.47x0.41x0.82x1.65x7.01x10.10x0.31x3.45x3.02x2.67x
Revenue YoY growth-14.3%-10.6%10.5%37.3%80.3%25.1%-43.9%-35.8%111.8%Unavailable
Net margin-120.6%-62.1%-109.9%-169.7%-99.0%-341.0%-643.4%-169.8%-67.8%-140.8%
R&D / revenue44.0%36.2%30.9%46.3%46.0%49.2%58.7%35.0%26.3%67.5%
CapEx / revenue0.2%0.2%0.0%1.2%0.8%1.3%1.3%1.3%2.6%1.8%
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open BKYI in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-13View SEC filing
10-Q · Filed 2026-06-22View SEC filing
10-K · Filed 2026-06-12View SEC filing
10-Q · Filed 2025-11-14View SEC filing
10-Q · Filed 2025-08-13View SEC filing
10-Q · Filed 2025-05-15View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.